Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
The Supreme Court of Justice of the United States in Association for Molecular Pathology vs Myriad Genetics, Inc rules out patents over isolated dna as they were not different from products of nature, yet it maintains patents over synthetizes genes or dnac. This decision has redefined the scope of t...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Universidad Externado de Colombia
2013
|
| Subjects: | |
| Online Access: | http://dialnet.unirioja.es/servlet/oaiart?codigo=4775088 |
| Source: | Revista la propiedad inmaterial, ISSN 1657-1959, Nº. 17, 2013, pags. 263-281 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| id |
dialnet-ar-18-ART0000669282
|
|---|---|
| record_format |
dialnet
|
| spelling |
dialnet-ar-18-ART00006692822016-04-13Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.Conde Gutiérrez, Carlos AugustoDíaz, Lina MaríaPatenteadnadncproducto de la naturalezaMyriad GeneticsTribunal Andino de JusticiaPatentdnadnacproducts of natureMyriad GeneticsAndean Tribunal of JusticeThe Supreme Court of Justice of the United States in Association for Molecular Pathology vs Myriad Genetics, Inc rules out patents over isolated dna as they were not different from products of nature, yet it maintains patents over synthetizes genes or dnac. This decision has redefined the scope of the doctrine of products of nature on biotechnological invention as established by Diamond vs Chakrabarty. Coincidentally, the Supreme Court´s new interpretation is in harmony with the Andean Tribunal of Justice´ rulings. This article analyses the doctrine of products of nature in the light of Association for Molecular Pathology vs Myriad Genetics, Inc, its implications for the biotechnological industry and the jurisprudence of the Andean Tribunal of Justice.La Corte Suprema de Justicia de Estados Unidos, en el caso Association for Molecular Pathology v. Myriad Genetics, Inc., revocó patentes que reivindicaban secuencias de adn aislado, por considerar que no son diferentes de los productos de la naturaleza, aunque otras patentes sobre genes que han sido sintetizados (adnc) resultaron indemnes. Esta decisión redefinió el alcance de la doctrina de los productos de la naturaleza en invenciones biotecnológicas como había sido establecido en Diamond v. Chakrabart; adicionalmente, esta nueva reinterpretación de la Corte se armoniza con lo establecido con anterioridad por el Tribunal de Justicia Andino. El presente artículo analiza la doctrina de los productos de la naturaleza a la luz del caso Association for Molecular Pathology v. Myriad Genetics, Inc., sus implicaciones para la industria biotecnológica a nivel mundial y la jurisprudencia del Tribunal Andino de Justicia frente al tema.Universidad Externado de Colombia2013text (article)application/pdfhttp://dialnet.unirioja.es/servlet/oaiart?codigo=4775088(Revista) ISSN 1657-1959Revista la propiedad inmaterial, ISSN 1657-1959, Nº. 17, 2013, pags. 263-281spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: http://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: http://dialnet.unirioja.es/info/derechosOAI
|
| institution |
Dialnet
|
| collection |
Dialnet AR
|
| source |
Revista la propiedad inmaterial, ISSN 1657-1959, Nº. 17, 2013, pags. 263-281
|
| language |
Spanish
|
| topic |
Patente
adn adnc producto de la naturaleza Myriad Genetics Tribunal Andino de Justicia Patent dna dnac products of nature Myriad Genetics Andean Tribunal of Justice |
| spellingShingle |
Patente
adn adnc producto de la naturaleza Myriad Genetics Tribunal Andino de Justicia Patent dna dnac products of nature Myriad Genetics Andean Tribunal of Justice Conde Gutiérrez, Carlos Augusto Díaz, Lina María Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc. |
| description |
The Supreme Court of Justice of the United States in Association for Molecular
Pathology vs Myriad Genetics, Inc rules out patents over isolated dna as they were
not different from products of nature, yet it maintains patents over synthetizes
genes or dnac. This decision has redefined the scope of the doctrine of products
of nature on biotechnological invention as established by Diamond vs Chakrabarty.
Coincidentally, the Supreme Court´s new interpretation is in harmony with the
Andean Tribunal of Justice´ rulings. This article analyses the doctrine of products
of nature in the light of Association for Molecular Pathology vs Myriad Genetics,
Inc, its implications for the biotechnological industry and the jurisprudence of
the Andean Tribunal of Justice.
|
| format |
Article
|
| author |
Conde Gutiérrez, Carlos Augusto
Díaz, Lina María |
| author_facet |
Conde Gutiérrez, Carlos Augusto
Díaz, Lina María |
| author_sort |
Conde Gutiérrez, Carlos Augusto
|
| title |
Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
|
| title_short |
Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
|
| title_full |
Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
|
| title_fullStr |
Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
|
| title_full_unstemmed |
Productos de la naturaleza y el Caso Association for Molecular Pathology V. Myriad Genetics, Inc.
|
| title_sort |
productos de la naturaleza y el caso association for molecular pathology v. myriad genetics, inc.
|
| publisher |
Universidad Externado de Colombia
|
| publishDate |
2013
|
| url |
http://dialnet.unirioja.es/servlet/oaiart?codigo=4775088
|
| _version_ |
1709712974515535872
|